T cell responses during allergen-specific immunotherapy of Type i allergy

Frontiers in Bioscience

Volumn 13, Issue 16, 2008, Pages 6079-6085

  Bohle, Barbara ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Regulatory T cells; Review; T cells; Th1; Th2; Type I allergy

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT;

ANTIGEN PRESENTING CELL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; METHODOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ALLERGENS; ANTI-ALLERGIC AGENTS; ANTIGEN-PRESENTING CELLS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOSUPPRESSION; IMMUNOTHERAPY; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 52049103096     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3139     Document Type: Article

References (75)

1. J. Bousquet, R. Lockey and H. Malling: World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 53, 20-22 (1998)
2. L. Noon: Prophylactic inoculation against hay fever. Lancet 2(1572-73 (1911)
3. J. Freemann: Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 2, 814-817 (1911)
4. R. Cooke, J. Barnard, S. Hebald and A. Stull: Serological evidence of immunity with coexisting stensitization in a type of human allergy. J Exp Med 62, 733-750 (1935)
5. M. E. Devey, D. V. Wilson and A. W. Wheeler: The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization. Clin Allergy 6, 227-236 (1976)
6. R. Djurup: The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy 40, 469-486 (1985) (Pubitemid 16235542)
7. P. Jeannin, S. Lecoanet, Y. Delneste, J. F. Gauchat and J. Y. Bonnefoy: IgE versus IgG4 production can be differentially regulated by IL-10. J Immuno. 160, 3555-3561 (1998) (Pubitemid 28164751)
8. F. M. Lu, C. C. Chou, B. L. Chiang and K. H. Hsieh: Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. Ann Allergy Asthma Immuno. 80, 419-423 (1998)
9. K. Gehlhar, M. Schlaak, W. Becker and A. Bufe: Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 29, 497-506 (1999) (Pubitemid 29179819)
10. R. J. van Neerven, M. Arvidsson, H. Ipsen, S. H. Sparholt, S. Rak and P. A. Wurtzen: A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin Efacilitated allergen presentation. Clin Exp Allergy 34, 420-428 (2004) (Pubitemid 38373005)
11. J. S. Satoguina, E. Weyand, J. Larbi and A. Hoerauf: T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 174, 4718-4726 (2005) (Pubitemid 40514459)
12. B. E. Garcia, M. L. Sanz, J. J. Gato, J. Fernandez and A. Oehling: IgG4 blocking effect on the release of antigenspecific histamine. J Investig Allergol Clin Immunol 3, 26-33 (1993) (Pubitemid 23126659)
13. A. M. Witteman, S. O. Stapel, D. H. Sjamsoedin, H. M. Jansen, R. C. Aalberse and J. S. van der Zee: Fel d 1- specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int Arch Allergy Immunol 109, 369-375 (1996) (Pubitemid 26082845)
14. R. J. van Neerven, T. Wikborg, G. Lund, B. Jacobsen, A. Brinch-Nielsen, J. Arnved and H. Ipsen: Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgEfacilitated allergen presentation. J Immunol 163, 2944-2952 (1999) (Pubitemid 29399227)
15. P. A. Wachholz, N. K. Soni, S. J. Till and S. R. Durham: Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 112, 915-922 (2003) (Pubitemid 37412059)
16. T. Birkner, H. Rumpold, E. Jarolim, H. Ebner, M. Breitenbach, F. Skvaril, O. Scheiner and D. Kraft: Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 45, 418-426 (1990) (Pubitemid 20286256)
17. U. Bodtger, A. M. Ejrnaes, L. Hummelshoj, H. H. Jacobi, L. K. Poulsen and M. Svenson: Is immunotherapyinduced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity? Int Arch Allergy Immunol 136, 340-346 (2005) (Pubitemid 41094497)
18. E. A. Wierenga, M. Snoek, J. D. Bos, H. M. Jansen and M. L. Kapsenberg: Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol 20, 1519-1526 (1990) (Pubitemid 20233787)
19. P. Parronchi, D. Macchia, M. P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari and S. Romagnani: Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 88, 4538-4542 (1991) (Pubitemid 21914576)
20. C. Ebner, S. Schenk, N. Najafian, U. Siemann, R. Steiner, G. W. Fischer, K. Hoffmann, Z. Szepfalusi, O. Scheiner and D. Kraft: Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 154, 1932-1940 (1995)
21. S. R. Durham, S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay and Q. A. Hamid: Cytokine messenger RNA expression for IL-3, IL- 4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 148, 2390-2394 (1992)
22. Q. Hamid, M. Boguniewicz and D. Y. Leung: Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94, 870-876 (1994) (Pubitemid 24251022)
23. G. F. Del Prete, M. De Carli, M. M. D'Elios, P. Maestrelli, M. Ricci, L. Fabbri and S. Romagnani: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 23, 1445-1449 (1993) (Pubitemid 23218047)
24. K. J. Bodey, A. E. Semper, A. E. Redington, J. Madden, L. M. Teran, S. T. Holgate and A. J. Frew: Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 54, 1083-1093 (1999) (Pubitemid 29482008)
25. J. A. Bluestone and A. K. Abbas: Natural versus adaptive regulatory T cells. Nat Rev Immunol 3, 253-257 (2003) (Pubitemid 37323210)
26. H. L. Weiner: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182, 207-214 (2001) (Pubitemid 33070220)
27. M. K. Levings and M. G. Roncarolo: Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells. Curr Top Microbiol Immunol 293, 303-326 (2005) (Pubitemid 40791235)
28. I. Bellinghausen, J. Knop and J. Saloga: The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 126, 97-101 (2001) (Pubitemid 33135386)
29. P. Stock, O. Akbari, G. Berry, G. J. Freeman, R. H. Dekruyff and D. T. Umetsu: Induction of T helper type 1- like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 5, 1149-1156 (2004) (Pubitemid 39549629)
30. E. M. Ling, T. Smith, X. D. Nguyen, C. Pridgeon, M. Dallman, J. Arbery, V. A. Carr and D. S. Robinson: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608-615 (2004) (Pubitemid 38264178)
31. I. Bellinghausen, B. Konig, I. Bottcher, J. Knop and J. Saloga: Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 116, 103-111 (2005) (Pubitemid 41208357)
32. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, C. Kegel, R. Disch, C. B. Schmidt- Weber, K. Blaser and C. A. Akdis: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199, 1567-1575 (2004) (Pubitemid 38780411)
33. M. R. Karlsson, J. Rugtveit and P. Brandtzaeg: Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199, 1679-1688 (2004) (Pubitemid 38822001)
34. S. L. Reiner: Development in motion: helper T cells at work. Cell. 129, 33-6 (2007) (Pubitemid 46507593)
35. C. B. Schmidt-Weber, M. Akdis and C. A. Akdis: TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120, 247-254 (2007) (Pubitemid 47102403)
36. A. J. van Beelen, M. B. Teunissen, M. L. Kapsenberg and E. C. de Jong: Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 7, 374-81 (2007) (Pubitemid 47415279)
37. H. Garn and H. Renz: Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 212, 441-452 (2007) (Pubitemid 46825255)
38. H. Secrist, C. J. Chelen, Y. Wen, J. D. Marshall and D. T. Umetsu: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.Exp Med 178, 2123-2130 (1993) (Pubitemid 23344869)
39. M. Jutel, W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden and U. R. Muller: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFNgamma secretion in specific allergen-stimulated T cell cultures. J Immunol 154, 4187-4194 (1995)
40. C. A. Akdis, M. Akdis, T. Blesken, D. Wymann, S. S. Alkan, U. Muller and K. Blaser: Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 98, 1676-1683 (1996) (Pubitemid 26327879)
41. C. Ebner, U. Siemann, B. Bohle, M. Willheim, U. Wiedermann, S. Schenk, F. Klotz, H. Ebner, D. Kraft and O. Scheiner: Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 27, 1007-1015 (1997)
42. N. P. Eusebius, L. Papalia, C. Suphioglu, S. C. McLellan, M. Varney, J. M. Rolland and R. E. O'Hehir: Oligoclonal analysis of the atopic T cell response to the group 1 allergen of Cynodon dactylon (bermuda grass) pollen: pre- and post-allergen-specific immunotherapy. Int Arch Allergy Immunol 127, 234-244 (2002) (Pubitemid 34455093)
43. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser and C. A. Akdis: IL-10 and TGFbeta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33, 1205-1214 (2003) (Pubitemid 36609138)
44. M. M. Pienkowski, N. F. Adkinson, Jr., M. Plaut, P. S. Norman and L. M. Lichtenstein: Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. J Allergy Clin Immunol 82, 95-100 (1988)
45. V. A. Varney, Q. A. Hamid, M. Gaga, S. Ying, M. Jacobson, A. J. Frew, A. B. Kay and S. R. Durham: Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergeninduced late-phase cutaneous responses. J Clin Invest 92, 644-651 (1993) (Pubitemid 23262381)
46. S. R. Durham, S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay and Q. A. Hamid: Grass pollen immunotherapy inhibits allergeninduced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 97, 1356-1365 (1996)
47. Q. A. Hamid, E. Schotman, M. R. Jacobson, S. M. Walker and S. R. Durham: Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 99, 254-260 (1997) (Pubitemid 27091578)
48. I. Bellinghausen, G. Metz, A. H. Enk, S. Christmann, J. Knop and J. Saloga: Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 27, 1131-1139 (1997) (Pubitemid 27197215)
49. C. A. Akdis, T. Blesken, M. Akdis, B. Wuthrich and K. Blaser: Role of interleukin 10 in specific immunotherapy. J Clin Invest 102, 98-106 (1998) (Pubitemid 28323835)
50. J. N. Francis, S. J. Till and S. R. Durham: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111, 1255-1261 (2003) (Pubitemid 36683679)
51. L. M. Gardner, F. C. Thien, J. A. Douglass, J. M. Rolland and R. E. O'Hehir: Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 34, 1209-1219 (2004) (Pubitemid 39093059)
52. C. A. Akdis and K. Blaser: IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. Faseb J 13, 603-609 (1999) (Pubitemid 29156392)
53. C. A. Akdis, A. Joss, M. Akdis, A. Faith and K. Blaser: A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. Faseb J. 14(12), 1666-8 (2000)
54. D. R. Wilson, M. T. Lima and S. R. Durham: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60, 4-12 (2005)
55. Z. Calamita, H. Saconato, A. B. Pela and A. N. Atallah: Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 61, 1162-1172 (2006) (Pubitemid 44326350)
56. C. Fanta, B. Bohle, W. Hirt, U. Siemann, F. Horak, D. Kraft, H. Ebner and C. Ebner: Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 120, 218-224 (1999)
57. L. Cosmi, V. Santarlasci, R. Angeli, F. Liotta, L. Maggi, F. Frosali, O. Rossi, P. Falagiani, G. Riva, S. Romagnani, F. Annunziato and E. Maggi: Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10- production. Clin Exp Allergy. 36, 261-272 (2006) (Pubitemid 43344707)
58. T. Kinaciyan, B. Jahn-Schmid, A. Radakovics, B. Zwolfer, C. Schreiber, J. N. Francis, C. Ebner and B. Bohle: Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog al d 1. J Allergy Clin Immunol 119, 937-943 (2007) (Pubitemid 46527803)
59. E. Enrique, F. Pineda, T. Malek, J. Bartra, M. Basagana, R. Tella, J. V. Castello, R. Alonso, J. A. de Mateo, T. Cerda-Trias, M. San Miguel-Moncin Mdel, S. Monzon, M. Garcia, R. Palacios and A. Cistero-Bahima: Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116, 1073-1079 (2005) (Pubitemid 41571791)
60. G. Ciprandi, D. Fenoglio, I. Cirillo, A. Vizzaccaro, A. Ferrera, M. A. Tosca and F. Puppo: Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 95, 38-44 (2005) (Pubitemid 41022771)
61. C. Ebner, Z. Szepfalusi, F. Ferreira, A. Jilek, R. Valenta, P. Parronchi, E. Maggi, S. Romagnani, O. Scheiner and D. Kraft: Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 150, 1047-1054 (1993)
62. B. Jahn-Schmid, A. Radakovics, D. Luttkopf, S. Scheurer, S. Vieths, C. Ebner and B. Bohle: Bet v 1142- 156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1- related food allergens. J Allergy Clin Immunol 116, 213-219 (2005)
63. T. Nagato, H. Kobayashi, M. Yanai, K. Sato, N. Aoki, K. Oikawa, S. Kimura, Y. Abe, E. Celis, Y. Harabuchi and M. Tateno: Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. J Immunol 178, 1189-1198 (2007) (Pubitemid 46095193)
64. M. Vanek-Krebitz, K. Hoffmann-Sommergruber, M. Laimer da Camara Machado, M. Susani, C. Ebner, D. Kraft, O. Scheiner and H. Breiteneder: Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun 214, 538-551 (1995)
65. D. Luttkopf, U. Muller, P. S. Skov, B. K. Ballmer- Weber, B. Wuthrich, K. Skamstrup Hansen, L. K. Poulsen, M. Kastner, D. Haustein and S. Vieths: Comparison of four variants of a major allergen in hazelnut (Corylus avellana) Cor a 1.0.4 with the major hazel pollen allergen Cor a 1.0.1. Mol Immunol 38, 515-525 (2002) (Pubitemid 34031840)
66. H. Breiteneder, K. Hoffmann-Sommergruber, G. O'Riordain, M. Susani, H. Ahorn, C. Ebner, D. Kraft and O. Scheiner: Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens. Eur J Biochem 233, 484-489 (1995)
67. K. Hoffmann-Sommergruber, G. O'Riordain, H. Ahorn, C. Ebner, M. Laimer Da Camara Machado, H. Puhringer, O. Scheiner and H. Breiteneder: Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1. Clin Exp Allergy 29, 840-847 (1999) (Pubitemid 29268475)
68. R. Fritsch, B. Bohle, U. Vollmann, U. Wiedermann, B. Jahn-Schmid, M. Krebitz, H. Breiteneder, D. Kraft and C. Ebner: Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. J Allergy Clin Immunol 102, 679-686 (1998)
69. B. Bohle, A. Radakovics, B. Jahn-Schmid, K. Hoffmann-Sommergruber, G. F. Fischer and C. Ebner: Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level. Eur J Immunol 33, 3303-3310 (2003)
70. B. Bohle, A. Radakovics, D. Luttkopf, B. Jahn-Schmid, S. Vieths and C. Ebner: Characterization of the T cell response to the major hazelnut allergen, Cor a 1.0.4: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens. Clin Exp Allergy 35, 1392-1399 (2005)
71. B. Bohle, T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schmid and C. Ebner: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergenspecific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120, 707-713 (2007) (Pubitemid 47320765)
72. S. Hori and S. Sakaguchi: Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6, 745-751 (2004) (Pubitemid 38781186)
73. E. Mamessier, J. Birnbaum, P. Dupuy, D. Vervloet and A. Magnan: Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy. Clin Exp Allergy 36, 704-713 (2006) (Pubitemid 43972965)
74. S. M. Nasser, S. Ying, Q. Meng, A. B. Kay and P. W. Ewan: Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur J Immunol 31, 3704-3713 (2001) (Pubitemid 34030984)
75. M. Vukmanovic-Stejic, Y. Zhang, J. E. Cook, J. M. Fletcher, A. McQuaid, J. E. Masters, M. H. Rustin, L. S. Taams, P. C. Beverley, D. C. Macallan and A. N. Akbar: Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116, 2423-2433 (2006) (Pubitemid 44330141)